Loading…
Loading grant details…
| Funder | Wellcome Trust |
|---|---|
| Recipient Organization | Clinton Health Access Initiative |
| Country | United Kingdom |
| Start Date | Sep 09, 2024 |
| End Date | Sep 08, 2027 |
| Duration | 1,094 days |
| Number of Grantees | 1 |
| Roles | Award Holder |
| Data Source | Europe PMC |
| Grant ID | 309189 |
Dengue poses a significant and growing global health threat.
Mosquito resistance to insecticides is spreading even as global warming and urbanization expand Aedes habitat, increasing risk of dengue and other Aedes- borne viral diseases.
Demonstration that certain strains of Wolbachia can inhibit viral growth in the vector offers a sustainable tool to counteract the increasing risk of these diseases.
Implementations by World Mosquito Program and others have produced impressive results, but scaling this innovation to all at risk requires a global ecosystem of government-led programs, donors, and suppliers that does not exist today.
CHAI and HFC aim to develop the global ecosystem needed to scale Wolbachia-based solutions to mitigate the growing threat of dengue and other arboviruses by: (1) Incorporating Wolbachia-based tools into evidence-based, government-owned national dengue strategies in 4+ countries while gathering intelligence on demand and budget requirements across Central America, Southeast Asia, and sub-Saharan Africa; (2) Quantifying regional supply requirements and engaging suppliers to ensure necessary supply and technical expertise exists to meet demand; (3) Developing financing mechanisms to fund Wolbachia deployment across diverse settings.
Together these interrelated workstreams will catalyze scale-up by simultaneously stimulating demand, financing, and affordable supply to realize the potential of this critical health innovation.
Clinton Health Access Initiative
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant